Abeona Therapeutics (ABEO) News Today $6.59 -0.04 (-0.60%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$6.62 +0.03 (+0.38%) As of 07/18/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Abeona Therapeutics Inc. (NASDAQ:ABEO) About To Shift From Loss To ProfitJuly 17 at 8:34 AM | finance.yahoo.comAbeona Therapeutics (NASDAQ:ABEO) Earns "Buy" Rating from HC WainwrightJuly 16, 2025 | americanbankingnews.comZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay AreaJuly 15, 2025 | tmcnet.comZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay AreaJuly 15, 2025 | globenewswire.comBio-Techne Corporation: Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene TherapyJuly 14, 2025 | finanznachrichten.deAbeona Therapeutics' (ABEO) Buy Rating Reiterated at HC WainwrightJuly 14, 2025 | marketbeat.comBio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene TherapyJuly 14, 2025 | prnewswire.comFaith L. Charles Sells 10,738 Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO) StockJuly 11, 2025 | insidertrades.comInsider Selling: Abeona Therapeutics Inc. (NASDAQ:ABEO) Director Sells 10,738 Shares of StockJuly 10, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Director Sells $76,724.98 in StockJuly 10, 2025 | marketbeat.comInsider Selling: Abeona Therapeutics Inc. (NASDAQ:ABEO) Director Sells 13,093 Shares of StockJuly 10, 2025 | marketbeat.comInsider Selling: Abeona Therapeutics Inc. (NASDAQ:ABEO) SVP Sells 17,428 Shares of StockJuly 10, 2025 | marketbeat.comJoseph Walter Vazzano Sells 25,411 Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO) StockJuly 10, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 69,420 SharesJuly 10, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Recommendation of "Buy" from AnalystsJuly 8, 2025 | marketbeat.comAbeona Therapeutics Inc. (ABEO) Balance Sheet - Yahoo FinanceJuly 4, 2025 | finance.yahoo.comAbeona therapeutics closes sale of priority review voucher for $155 million - Investing.comJuly 3, 2025 | investing.comAbeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million - MorningstarJuly 3, 2025 | morningstar.comMAbeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million - Seeking AlphaJuly 3, 2025 | seekingalpha.comAbeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 MillionJuly 2, 2025 | globenewswire.comAbeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index - Seeking AlphaJuly 2, 2025 | seekingalpha.comAbeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene TherapyJuly 1, 2025 | globenewswire.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 1, 2025 | globenewswire.comAbeona Therapeutics added to U.S. Small-cap Russell 2000 and Russell 3000 IndexesJune 30, 2025 | seekingalpha.comAbeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® IndexJune 30, 2025 | globenewswire.comABEO Abeona Therapeutics Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comAbeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis BullosaJune 24, 2025 | globenewswire.comAbeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Above 50 Day Moving Average - What's Next?June 21, 2025 | marketbeat.comBavarian Nordic nets $160m from priority review voucher saleJune 18, 2025 | msn.comAbeona Therapeutics Inc (NASDAQ:ABEO) Receives Average Recommendation of "Buy" from AnalystsJune 13, 2025 | marketbeat.comBrokers Offer Predictions for ABEO FY2026 EarningsJune 10, 2025 | marketbeat.comWellington Management Group LLP Invests $520,000 in Abeona Therapeutics Inc (NASDAQ:ABEO)June 8, 2025 | marketbeat.comBrendan M. O'malley Sells 10,470 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockJune 7, 2025 | insidertrades.comAbeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Sells 10,470 SharesJune 6, 2025 | marketbeat.comInsider Selling: Abeona Therapeutics Inc (NASDAQ:ABEO) CFO Sells 17,795 Shares of StockJune 6, 2025 | marketbeat.comVishwas Seshadri Sells 50,676 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockJune 6, 2025 | marketbeat.comAbeona Therapeutics: Substantially Undervalued Post-FDA Approval (Rating Upgrade)June 5, 2025 | seekingalpha.comOppenheimer assumes coverage on Abeona Therapeutics stockJune 4, 2025 | uk.investing.comAbeona Therapeutics (NASDAQ:ABEO) Now Covered by Analysts at OppenheimerJune 2, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 2, 2025 | globenewswire.comAbeona Therapeutics® to Present at the Jefferies Global Healthcare ConferenceMay 30, 2025 | finance.yahoo.comAbeona Therapeutics® to Present at the Jefferies Global Healthcare ConferenceMay 30, 2025 | globenewswire.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Sells $12,760.00 in StockMay 29, 2025 | marketbeat.comMark Alvino Sells 2,000 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockMay 28, 2025 | insidertrades.comJane Street Group LLC Purchases 118,262 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO)May 27, 2025 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Stock Holdings Reduced by Millennium Management LLCMay 26, 2025 | marketbeat.comFY2025 Earnings Forecast for ABEO Issued By Zacks Small CapMay 24, 2025 | marketbeat.comFY2025 EPS Estimates for ABEO Lifted by Cantor FitzgeraldMay 23, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Outlook for ABEO EarningsMay 23, 2025 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) is Western Standard LLC's 3rd Largest PositionMay 22, 2025 | marketbeat.com Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address ABEO Media Mentions By Week ABEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.110.58▲Average Medical News Sentiment ABEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼83▲ABEO Articles Average Week Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) News Enliven Therapeutics News Structure Therapeutics News Cidara Therapeutics News Ardelyx News Praxis Precision Medicines News ProKidney News Collegium Pharmaceutical News Akebia Therapeutics News Amphastar Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
